E
Beta Bionics, Inc. BBNX
$10.80 -$0.16-1.46% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 12/31/2023
Total Cash And Short-Term Investments 70.08% --
Total Receivables 60.72% --
Inventory 17.97% --
Prepaid Expenses 14.78% --
Finance Division Loans and Leases Current -- --
Total Finance Division Other Current Assets -- --
Other Current Assets 244.26% --
Total Current Assets 61.01% --

Total Current Assets 61.01% --
Net Property, Plant & Equipment 3.49% --
Long-term Investments -- --
Goodwill -- --
Total Other Intangibles -- --
Finance Div Loans & Leases LT -- --
Total Finance Div Other LT Assets -- --
Total Other Assets 58.38% --
Total Assets 54.37% --

Total Accounts Payable 0.14% --
Total Accrued Expenses 16.35% --
Short-term Debt -- --
Current Portion of Long-Term Debt/Capital Leases -- --
Finance Division Debt Current 5.45% --
Total Finance Division Other Current Liabilities 61.88% --
Total Other Current Liabilities 61.88% --
Total Current Liabilities 18.28% --

Total Current Liabilities 18.28% --
Long-Term Debt -- --
Short-term Debt -- --
Capital Leases -2.14% --
Finance Division Debt Non Current -- --
Total Finance Division Other Non Current Liabilities -- --
Total Other Liabilities 15.90% --
Total Liabilities 14.92% --

Common Stock & APIC 3.19% --
Retained Earnings -6.50% --
Treasury Stock & Other 12.07% --
Total Common Equity -7.22% --

Preferred Stock Redeemable -- --
Preferred Stock Non Redeemable -- --
Preferred Stock Convertible 22.80% --
Preferred Stock, Others -- --
Total Preferred Equity 22.80% --

Total Common Equity -7.22% --
Total Preferred Equity 22.80% --
Total Minority Interest -- --
Total Equity 131.28% --